Free Trial

Autonomix Medical (AMIX) Competitors

Autonomix Medical logo
$3.54 -0.24 (-6.35%)
Closing price 04:00 PM Eastern
Extended Trading
$3.54 0.00 (0.00%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMIX vs. ICU, NMTC, TMDIF, IRIX, and ADGM

Should you buy Autonomix Medical stock or one of its competitors? Autonomix Medical's main competitors and comparable companies include SeaStar Medical (ICU), NeuroOne Medical Technologies (NMTC), Titan Medical (TMDIF), IRIDEX (IRIX), and Adagio Medical (ADGM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Autonomix Medical compare to SeaStar Medical?

SeaStar Medical (NASDAQ:ICU) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

Autonomix Medical has a net margin of 0.00% compared to SeaStar Medical's net margin of -795.51%. SeaStar Medical's return on equity of -162.75% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
SeaStar Medical-795.51% -162.75% -109.89%
Autonomix Medical N/A -267.73%-216.75%

SeaStar Medical currently has a consensus price target of $8.00, indicating a potential upside of 70.58%. Autonomix Medical has a consensus price target of $42.00, indicating a potential upside of 1,011.11%. Given Autonomix Medical's higher probable upside, analysts clearly believe Autonomix Medical is more favorable than SeaStar Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
SeaStar Medical
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

1.7% of SeaStar Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 0.7% of SeaStar Medical shares are owned by company insiders. Comparatively, 5.5% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, SeaStar Medical and SeaStar Medical both had 5 articles in the media. SeaStar Medical's average media sentiment score of 0.22 beat Autonomix Medical's score of 0.00 indicating that SeaStar Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
SeaStar Medical
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

SeaStar Medical has higher revenue and earnings than Autonomix Medical. SeaStar Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SeaStar Medical$1.23M16.82-$12.15M-$3.91N/A
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A

SeaStar Medical has a beta of -1.09, suggesting that its stock price is 209% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -0.96, suggesting that its stock price is 196% less volatile than the broader market.

Summary

SeaStar Medical and Autonomix Medical tied by winning 6 of the 12 factors compared between the two stocks.

How does Autonomix Medical compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, media sentiment, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations.

NeuroOne Medical Technologies currently has a consensus target price of $7.33, indicating a potential upside of 554.76%. Autonomix Medical has a consensus target price of $42.00, indicating a potential upside of 1,011.11%. Given Autonomix Medical's higher possible upside, analysts plainly believe Autonomix Medical is more favorable than NeuroOne Medical Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NeuroOne Medical Technologies
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

16.1% of NeuroOne Medical Technologies shares are held by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are held by institutional investors. 11.8% of NeuroOne Medical Technologies shares are held by insiders. Comparatively, 5.5% of Autonomix Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Autonomix Medical has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -71.50%. NeuroOne Medical Technologies' return on equity of -128.12% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
NeuroOne Medical Technologies-71.50% -128.12% -86.34%
Autonomix Medical N/A -267.73%-216.75%

NeuroOne Medical Technologies has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market. Comparatively, Autonomix Medical has a beta of -0.96, suggesting that its share price is 196% less volatile than the broader market.

In the previous week, Autonomix Medical had 3 more articles in the media than NeuroOne Medical Technologies. MarketBeat recorded 5 mentions for Autonomix Medical and 2 mentions for NeuroOne Medical Technologies. NeuroOne Medical Technologies' average media sentiment score of 0.49 beat Autonomix Medical's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NeuroOne Medical Technologies
0 Very Positive mention(s)
2 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NeuroOne Medical Technologies has higher revenue and earnings than Autonomix Medical. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NeuroOne Medical Technologies$12.10M0.84-$3.61M-$0.95N/A
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A

Summary

NeuroOne Medical Technologies beats Autonomix Medical on 11 of the 15 factors compared between the two stocks.

How does Autonomix Medical compare to Titan Medical?

Autonomix Medical (NASDAQ:AMIX) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.

Titan Medical's return on equity of -82.31% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -267.73% -216.75%
Titan Medical N/A -82.31%-51.47%

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 5.5% of Autonomix Medical shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Autonomix Medical had 5 more articles in the media than Titan Medical. MarketBeat recorded 5 mentions for Autonomix Medical and 0 mentions for Titan Medical. Autonomix Medical's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company Overall Sentiment
Autonomix Medical Neutral
Titan Medical Neutral

Autonomix Medical currently has a consensus price target of $42.00, indicating a potential upside of 1,011.11%. Given Autonomix Medical's stronger consensus rating and higher probable upside, research analysts clearly believe Autonomix Medical is more favorable than Titan Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Titan Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Titan Medical has higher revenue and earnings than Autonomix Medical. Autonomix Medical is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A
Titan Medical$17.63M0.71$6.95M$0.052.20

Autonomix Medical has a beta of -0.96, indicating that its share price is 196% less volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

Summary

Titan Medical beats Autonomix Medical on 7 of the 13 factors compared between the two stocks.

How does Autonomix Medical compare to IRIDEX?

Autonomix Medical (NASDAQ:AMIX) and IRIDEX (NASDAQ:IRIX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk.

Autonomix Medical has a net margin of 0.00% compared to IRIDEX's net margin of -6.88%. IRIDEX's return on equity of 0.00% beat Autonomix Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -267.73% -216.75%
IRIDEX -6.88%N/A -12.55%

In the previous week, Autonomix Medical had 3 more articles in the media than IRIDEX. MarketBeat recorded 5 mentions for Autonomix Medical and 2 mentions for IRIDEX. Autonomix Medical's average media sentiment score of 0.00 equaled IRIDEX'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
IRIDEX
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Autonomix Medical has a beta of -0.96, indicating that its stock price is 196% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market.

Autonomix Medical presently has a consensus target price of $42.00, suggesting a potential upside of 1,011.11%. IRIDEX has a consensus target price of $3.00, suggesting a potential upside of 366.42%. Given Autonomix Medical's higher possible upside, analysts clearly believe Autonomix Medical is more favorable than IRIDEX.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
IRIDEX
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

IRIDEX has higher revenue and earnings than Autonomix Medical. IRIDEX is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A
IRIDEX$52.67M0.21-$4.44M-$0.20N/A

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 5.5% of Autonomix Medical shares are held by company insiders. Comparatively, 8.6% of IRIDEX shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

IRIDEX beats Autonomix Medical on 8 of the 12 factors compared between the two stocks.

How does Autonomix Medical compare to Adagio Medical?

Autonomix Medical (NASDAQ:AMIX) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, analyst recommendations, valuation, profitability, risk, institutional ownership and media sentiment.

Autonomix Medical has a beta of -0.96, suggesting that its share price is 196% less volatile than the broader market. Comparatively, Adagio Medical has a beta of 0.01, suggesting that its share price is 99% less volatile than the broader market.

10.8% of Autonomix Medical shares are owned by institutional investors. Comparatively, 48.1% of Adagio Medical shares are owned by institutional investors. 5.5% of Autonomix Medical shares are owned by company insiders. Comparatively, 7.8% of Adagio Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Autonomix Medical presently has a consensus target price of $42.00, suggesting a potential upside of 1,011.11%. Adagio Medical has a consensus target price of $3.50, suggesting a potential upside of 2,186.09%. Given Adagio Medical's stronger consensus rating and higher probable upside, analysts plainly believe Adagio Medical is more favorable than Autonomix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Autonomix Medical
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Adagio Medical
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Autonomix Medical's return on equity of -267.73% beat Adagio Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Autonomix MedicalN/A -267.73% -216.75%
Adagio Medical N/A -661.85%-73.35%

In the previous week, Autonomix Medical had 4 more articles in the media than Adagio Medical. MarketBeat recorded 5 mentions for Autonomix Medical and 1 mentions for Adagio Medical. Autonomix Medical's average media sentiment score of 0.00 equaled Adagio Medical'saverage media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Autonomix Medical
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Adagio Medical
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Autonomix Medical has higher earnings, but lower revenue than Adagio Medical. Adagio Medical is trading at a lower price-to-earnings ratio than Autonomix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Autonomix MedicalN/AN/A-$16.72M-$41.57N/A
Adagio Medical$600K5.67-$25.08M-$1.48N/A

Summary

Adagio Medical beats Autonomix Medical on 9 of the 13 factors compared between the two stocks.

Get Autonomix Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMIX vs. The Competition

MetricAutonomix MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.67M$5.46B$7.14B$13.26B
Dividend YieldN/A1.79%2.53%17.34%
P/E Ratio-0.0925.76274.3226.20
Price / SalesN/A69.61616.8792.49
Price / CashN/A32.7327.2234.70
Price / Book0.336.0411.236.40
Net Income-$16.72M$146.97M$3.49B$381.07M
7 Day Performance-7.57%-0.95%-1.68%-0.65%
1 Month Performance-22.88%-4.28%-5.97%-4.51%
1 Year Performance-85.21%2.47%8.11%1.82%

Autonomix Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMIX
Autonomix Medical
1.7759 of 5 stars
$3.54
-6.3%
$42.00
+1,086.4%
-84.2%$3.67MN/AN/A11
ICU
SeaStar Medical
2.8367 of 5 stars
$3.53
flat
$8.00
+126.6%
-27.7%$15.56M$1.23MN/A2
NMTC
NeuroOne Medical Technologies
3.9761 of 5 stars
$1.34
-2.9%
$7.33
+447.3%
-79.9%$12.57M$9.47MN/A18
TMDIF
Titan Medical
N/A$0.11
+0.1%
N/A-77.1%$12.52M$17.63MN/A50
IRIX
IRIDEX
1.3773 of 5 stars
$0.63
-0.2%
$3.00
+373.2%
-46.4%$11.16M$52.67MN/A108

Related Companies and Tools


This page (NASDAQ:AMIX) was last updated on 10/5/2026 by MarketBeat.com Staff.
From Our Partners